Coala Life postpones the publication of year-end report for 2023

Regulatory

The Board of Directors of Coala-Life Group AB ("Coala Life" or the "Company") has decided to postpone the publication of the year-end report for 2023 to March 8, 2024. The reason for the postponement is that the work to secure the Company's liquidity and financial situation has resulted in a delay in the completion of the report. The previously communicated date for the publication was February 23, 2024.

About us

Coala-Life Group AB (“Coala Life” or the “Company”) founded in 2015, is a Cloud Based Software as a Service provider, and medical device developer and reseller, listed on Nasdaq First North Growth Market. The Company focuses on B2B solutions for managed Remote Patient Monitoring (“RPM”), offering medical care providers, primarily in the US, with a highly scalable, cost-efficient platform to remotely and virtually manage large volumes of patients suffering from chronic diseases. The company offers care providers a comprehensive solution and lifts the administrative work from the care providers regarding, amongst other things, follow-up, 24/7 monitoring, as well as the reimbursement process from state and private health insurance companies. Patients are monitored long-term in everyday life and typically have diabetes, obesity, and/or cardiovascular disease. 
For more information see www.coalalife.com

For more information, please contact:

Dan Pitulia, CEO Coala Life AB
+44 7849 257 532, dan.pitulia@coalalife.com
Robin Danielsson Källmark, Interim CFO Coala Life AB
+46 72 188 84 09, robin.danielsson.kallmark@coalalife.com

Certified Adviser
The Company’s Certified Adviser is Carnegie Investment Bank AB (publ).

Attachments

Coala Life postpones the publication of year-end report for 2023

Documents